Have a feature idea you'd love to see implemented?
Let us know!
CDNA CareDx Inc
Price (delayed)
$22.58
Market cap
$1.21B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.69
Enterprise value
$1.14B
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant
Highlights
The debt has declined by 18% year-on-year and by 6% since the previous quarter
CDNA's gross profit is up by 8% year-on-year and by 7% since the previous quarter
CareDx's EPS has plunged by 60% YoY but it has increased by 10% from the previous quarter
CareDx's net income has plunged by 59% YoY but it has increased by 10% from the previous quarter
The company's quick ratio fell by 14% YoY
Key stats
What are the main financial stats of CDNA
Market
Valuations
Earnings
Shares outstanding
53.63M
Market cap
$1.21B
Enterprise value
$1.14B
Price to earnings (P/E)
N/A
Price to book (P/B)
4.36
Price to sales (P/S)
3.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.64
Revenue
$312.78M
EBIT
-$155.13M
EBITDA
-$135.01M
Free cash flow
$2.12M
Per share
Balance sheet
Liquidity
EPS
-$2.69
Free cash flow per share
$0.04
Book value per share
$5.18
Revenue per share
$5.91
TBVPS
$7.49
Total assets
$476.99M
Total liabilities
$203.74M
Debt
$23.84M
Equity
$273.25M
Working capital
$252.65M
Debt to equity
0.09
Current ratio
4.1
Quick ratio
3.78
Net debt/EBITDA
0.53
Margins
Efficiency
Dividend
EBITDA margin
-43.2%
Gross margin
65.8%
Net margin
-45.9%
Operating margin
-50.1%
Return on assets
-30.8%
Return on equity
-54.4%
Return on invested capital
-64.8%
Return on capital employed
-39.2%
Return on sales
-49.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CDNA stock price
How has the CareDx stock price performed over time
Intraday
0.94%
1 week
4.78%
1 month
-3.79%
1 year
137.68%
YTD
88.17%
QTD
-27.69%
Financial performance
How have CareDx's revenue and profit performed over time
Revenue
$312.78M
Gross profit
$205.71M
Operating income
-$156.56M
Net income
-$143.56M
Gross margin
65.8%
Net margin
-45.9%
CareDx's net income has plunged by 59% YoY but it has increased by 10% from the previous quarter
The operating income has dropped by 57% year-on-year but it rose by 10% since the previous quarter
The net margin has dropped by 50% year-on-year but it has grown by 15% since the previous quarter
CareDx's operating margin has decreased by 49% YoY but it has increased by 15% from the previous quarter
Growth
What is CareDx's growth rate over time
Valuation
What is CareDx stock price valuation
P/E
N/A
P/B
4.36
P/S
3.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.64
CareDx's EPS has plunged by 60% YoY but it has increased by 10% from the previous quarter
The equity has decreased by 31% YoY but it has increased by 3.2% from the previous quarter
The stock's price to book (P/B) is 28% more than its last 4 quarters average of 3.4 but 15% less than its 5-year quarterly average of 5.1
The price to sales (P/S) is 45% less than the 5-year quarterly average of 6.9 but 23% more than the last 4 quarters average of 3.1
The revenue has increased by 5% QoQ and by 5% YoY
Efficiency
How efficient is CareDx business performance
The ROE has plunged by 148% YoY
The ROIC has shrunk by 101% YoY but it rose by 4.7% QoQ
CDNA's return on assets has dropped by 78% year-on-year but it is up by 9% since the previous quarter
CareDx's ROS has decreased by 46% YoY but it has increased by 14% from the previous quarter
Dividends
What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CDNA.
Financial health
How did CareDx financials performed over time
The company's total assets is 134% higher than its total liabilities
CareDx's total liabilities has soared by 90% YoY
The company's quick ratio fell by 14% YoY
The debt is 91% smaller than the equity
The equity has decreased by 31% YoY but it has increased by 3.2% from the previous quarter
CareDx's debt to equity has increased by 29% YoY but it has decreased by 10% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.